0001576885-23-000052.txt : 20230818
0001576885-23-000052.hdr.sgml : 20230818
20230818183127
ACCESSION NUMBER: 0001576885-23-000052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230817
FILED AS OF DATE: 20230818
DATE AS OF CHANGE: 20230818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ives Jeffrey L.
CENTRAL INDEX KEY: 0001614096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40551
FILM NUMBER: 231186938
MAIL ADDRESS:
STREET 1: C/O CARA THERAPEUTICS, INC.
STREET 2: 1 PARROTT DRIVE
CITY: SHELTON
STATE: CT
ZIP: 06484
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acumen Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001576885
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 364108129
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 427 PARK ST.
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: 925-368-8508
MAIL ADDRESS:
STREET 1: 427 PARK ST.
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
4
1
wk-form4_1692397878.xml
FORM 4
X0508
4
2023-08-17
0
0001576885
Acumen Pharmaceuticals, Inc.
ABOS
0001614096
Ives Jeffrey L.
C/O ACUMEN PHARMACEUTICALS, INC.
427 PARK STREET
CHARLOTTESVILLE
VA
22902
1
0
0
0
1
Common Stock
2023-08-17
4
M
0
39149
0.72
A
39149
D
Common Stock
2023-08-17
4
S
0
39149
6.48
D
0
D
Common Stock
2023-08-17
4
M
0
2800
1.19
A
2800
D
Common Stock
2023-08-17
4
S
0
2800
6.66
D
0
D
Stock Option (right to buy)
0.72
2023-08-17
4
M
0
39149
0
D
2029-03-01
Common Stock
39149
0
D
Stock Option (right to buy)
1.19
2023-08-17
4
M
0
2800
0
D
2031-01-03
Common Stock
2800
0
D
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on May 17, 2023.
The option is fully vested.
/s/ Derek Meisner, Attorney-in-Fact
2023-08-18